Drug Type siRNA |
Synonyms SLN140 |
Target |
Action inhibitors |
Mechanism PROS1 inhibitors(protein S inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Hemophilia | Preclinical | Germany | 15 Nov 2022 | |
| Hemophilia | Preclinical | Switzerland | 15 Nov 2022 | |
| Hemophilia | Preclinical | Switzerland | 15 Nov 2022 | |
| Hemophilia | Preclinical | United Kingdom | 15 Nov 2022 |





